Press Releases for SCRX

Press Releases
Shionogi Completes Acquisition of Sciele
Shionogi and Sciele Announce Completion of Subsequent Offering Period
Shionogi and Sciele Announce Successful Tender Offer and Commencement of Subsequent Offering
Sciele Pharma Announces That Plethora Solutions Has Completed European Phase III Trial of PSD502 for Premature Ejaculation
Standard & Poor's Announces Update to the U.S. Market Cap Guidelines and Changes to U.S. Indices - Sep 25 2008 7:47PM
Shionogi and Sciele Announce Receipt of United States Antitrust Clearance
Sciele Completes Pivotal Phase III Program for Glycopyrrolate in Pediatric Patients with Chronic, Moderate-to-Severe Drooling
Sciele Pharma and Addrenex Pharmaceuticals Announce Positive Phase III Clinical Results of Clonicel for ADHD
Sciele Pharma, Inc. Gives Notice of Anticipated Effective Date of Make-Whole Fundamental Change to Holders of Convertible Notes
Shionogi & Co., Ltd. to Acquire Sciele Pharma, Inc.
Sciele Pharma, Inc. Reports Results for the Second Quarter of 2008
BellwetherReport.Com Analyst Report on SINA, BIDU, SCRX and KLAC
Sciele Pharma Announces That the FDA Has Issued an Approvable Letter for the Head Lice Treatment
Sciele Pharma Announces Second Quarter 2008 Earnings Release Date and Conference Call
Sciele Pharma Signs Agreement with Addrenex Pharmaceuticals To Develop and Market ADX415 for the Treatment of Hypertension
FDA Approves PrandiMet(TM), a Replaglinide and Metformin Fixed-Dose Combination Tablet for Treatment of Type 2 Diabetes
Sciele Pharma to Present at the Goldman Sachs 29th Annual Global Healthcare Conference
Sciele Pharma Announces That Addrenex Has Completed Enrollment of Pivotal Phase III Trial for Clonicel for ADHD
Sciele Pharma to Present at the UBS Global Specialty and Generic Pharmaceuticals Conference - May 26 2008 10:32PM
Sciele Pharma to Present at Bank of America Health Care Conference - Jun 2 2008 3:17AM
Sciele Pharma, Inc. Reports Results for the First Quarter of 2008
Sciele Pharma, Inc. Adopts $100 Million Share Repurchase Program
Sciele Pharma Announces FDA Acceptance of NDA for Addrenex Pharmaceuticals' CloniBID to Treat Hypertension
Sciele Pharma Announces First Quarter 2008 Earnings Release Date and Conference Call